Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation.
Crump NT. et al, (2021), Cell rep, 35
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
Godfrey L. et al, (2021), Leukemia, 35, 90 - 106
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation.
Godfrey L. et al, (2019), Nat commun, 10
PF153 MLL‐AF4 CAUSES ABERRANT UPREGULATION OF PROM1 (CD133) IN ACUTE LYMPHOBLASTIC LEUKEMIA BY CONTROLLING ENHANCER‐PROMOTER INTERACTIONS
Godfrey L. et al, (2019), Hemasphere, 3, 29 - 29